Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis

References

• LibbyPRidkerPMMaseriAInflammation and atherosclerosisCirculation200210591135114311877368
   PubMed Web of Science ®Google Scholar
• LintonMFFazioSMacrophages, inflammation, and atherosclerosisInt J Obes Relat Metab Disord200327Suppl 3S35S4014704742
   PubMedGoogle Scholar
• LessnerSMPradoHLWallerEKGalisZSAtherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine modelAm J Pathol200216062145215512057918
   PubMedGoogle Scholar
• ManduteanuISimionescuMInflammation in atherosclerosis: a cause or a result of vascular disorders?J Cell Mol Med20121691978199022348535
   PubMed Web of Science ®Google Scholar
• HanssonGKInflammatory mechanisms in atherosclerosisJ Thromb Haemost20097Suppl 132833119630827
   PubMedGoogle Scholar
• WongWW-LDimitroulakosJMindenMDPennLZHMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosisLeukemia200216450851911960327
   PubMed Web of Science ®Google Scholar
• TaylorAJKentSMFlahertyPJCoyleLCMarkwoodTTVernalisMNARBITER: Arterial biology for the investigation of the treatment effects of reducing cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thicknessCirculation2002106162055206012379573
   PubMed Web of Science ®Google Scholar
• AydinUUgurlucanMGungorFEffects of atorvastatin on vascular intimal hyperplasia: an experimental rodent modelAngiology200960337037718796450
   PubMedGoogle Scholar
• ThompsonPDPanzaGZaleskiATaylorBStatin-associated side effectsJ Am Coll Cardiol201667202395241027199064
   PubMed Web of Science ®Google Scholar
• ElshamaSSEl-KenawyAE-MOsmanH-EHCurcumin improves atorvastatin-induced myotoxicity in rats: histopathological and biochemical evidenceInt J Immunopathol Pharmacol201629474275227507589
   PubMedGoogle Scholar
• SahebkarASaboniNPirroMBanachMCurcumin: an effective adjunct in patients with statin-associated muscle symptoms?J Cachexia Sarcopenia Muscle201781192427897416
   PubMed Web of Science ®Google Scholar
• BanachMPattiAMGiglioRVThe role of nutraceuticals in statin intolerant patientsJ Am Coll Cardiol20187219611829957236
   PubMed Web of Science ®Google Scholar
• Michalska-KasiczakMSahebkarAMikhailidisDPAnalysis of vitamin D levels in patients with and without statin-associated myalgia – a systematic review and meta-analysis of 7 studies with 2420 patientsInt J Cardiol201517811111625464233
   PubMed Web of Science ®Google Scholar
• AnandPKunnumakkaraABNewmanRAAggarwalBBBioavailability of curcumin: problems and promisesMol Pharm20074680781817999464
   PubMed Web of Science ®Google Scholar
• AggarwalBBHarikumarKBPotential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesInt J Biochem Cell Biol2009411405918662800
   PubMed Web of Science ®Google Scholar
• AggarwalBBKumarABhartiACAnticancer potential of curcumin: preclinical and clinical studiesAnticancer Res2003231A36339812680238
   PubMed Web of Science ®Google Scholar
• Simental-MendíaLEPirroMGottoAMLipid-modifying activity of curcuminoids: a systematic review and meta-analysis of randomized controlled trialsCrit Rev Food Sci Nutr201740110
   Google Scholar
• GanjaliSBlessoCNBanachMPirroMMajeedMSahebkarAEffects of curcumin on HDL functionalityPharmacol Res201711920821828192240
   PubMed Web of Science ®Google Scholar
• OlszaneckiRJawieńJGajdaMEffect of curcumin on atherosclerosis in apoE/LDLR-double knockout miceJ Physiol Pharmacol200556462763516391419
   PubMed Web of Science ®Google Scholar
• SahebkarAKotaniKSerbanCStatin therapy reduces plasma endothelin-1 concentrations: a meta-analysis of 15 randomized controlled trialsAtherosclerosis2015241243344226074317
   PubMed Web of Science ®Google Scholar
• SerbanCSahebkarAUrsoniuSMikhailidisDPRizzoMA systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrationsSci Rep2015241199
   Google Scholar
• KhadkaPRoJKimHPharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailabilityAsian J Pharm201496304316
   Google Scholar
• KalashnikovaIMazarJNealCJNanoparticle delivery of cur-cumin induces cellular hypoxia and ROS-mediated apoptosis via modulation of Bcl-2/Bax in human neuroblastomaNanoscale2017929103751038728702620
   PubMed Web of Science ®Google Scholar
• XuPYuHZhangZHydrogen-bonded and reduction-responsive micelles loading atorvastatin for therapy of breast cancer metastasisBiomaterials201435267574758724899527
   PubMed Web of Science ®Google Scholar
• AlupeiMCLicareteEPatrasLBanciuMLiposomal simvastatin inhibits tumor growth via targeting tumor-associated macrophages-mediated oxidative stressCancer Lett20153562 Pt B94695225444912
   PubMed Web of Science ®Google Scholar
• MalamYLoizidouMSeifalianAMLiposomes and nanoparticles: nano-sized vehicles for drug delivery in cancerTrends Pharmacol Sci2009301159259919837467
   PubMed Web of Science ®Google Scholar
• YinTWangPLiJTumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomesBiomaterials201435225932594324746965
   PubMed Web of Science ®Google Scholar
• HeCTangZTianHChenXCo-delivery of chemotherapeutics and proteins for synergistic therapyAdv Drug Deliv Rev201698647626546464
   PubMed Web of Science ®Google Scholar
• TakaraKHatakeyamaHKibriaGOhgaNHidaKHarashimaHSize-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapyJ Control Release2012162122523222728515
   PubMed Web of Science ®Google Scholar
• LiuJJiangXAshleyCBrinkerCJElectrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and deliveryJ Am Chem Soc2009131227567756919445508
   PubMedGoogle Scholar
• SapraPTyagiPAllenTLigand-targeted liposomes for cancer treatmentCurr Drug Delivery200524369381
   PubMedGoogle Scholar
• StefanickJFAshleyJDKiziltepeTBilgicerBA systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomesACS Nano2013742935294723421406
   PubMed Web of Science ®Google Scholar
• YangYYangYXieXDual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting deliveryBiomaterials201548849625701034
   PubMed Web of Science ®Google Scholar
• ChenCDuanZYuanYPeptide-22 and cyclic RGD functionalized liposomes for glioma targeting drug delivery overcoming BBB and BBTBACS Appl Mater Interfaces2017975864587328128553
   PubMed Web of Science ®Google Scholar
• EvertsMSchraaAJde LeijLMeijerDKFMolemaGVascular endothelium in inflamed tissue as a target for site selective delivery of drugsMolemaGMeijerDKFDrug Targeting: Organ-Specific StrategiesWeinheimWiley-VCH200112171197
   Google Scholar
• LeusNGTalmanEGRamanaPEffective siRNA delivery to inflamed primary vascular endothelial cells by anti-E-selectin and anti-VCAM-1 PEGylated SAINT-based lipoplexesInt J Pharm20144591–2405024239833
   PubMedGoogle Scholar
• MoraneLHLyTNicolasRProinflammatory signature of the dysfunctional endothelium in pulmonary hypertension. Role of the macrophage migration inhibitory factor/CD74 complexAm J Resp Crit Care20151928983997
   PubMedGoogle Scholar
• JubeliEMoineLVergnaud-GauduchonJBarrattGE-selectin as a target for drug delivery and molecular imagingJ Control Release2012158219420621983284
   PubMed Web of Science ®Google Scholar
• BhaskarVLawDAIbsenEE-selectin up-regulation allows for targeted drug delivery in prostate cancerCancer Res200363196387639414559828
   PubMed Web of Science ®Google Scholar
• GhalandarlakiNAlizadehAMAshkani-EsfahaniSNanotechnology-applied curcumin for different diseases therapyBiomed Res Int20143394264
   Google Scholar
• KumarNChaurasiaSPatelRRKumarVMishraBDevelopment and optimization of atorvastatin calcium loaded oral biodegradable polymeric nanoparticles using central composite designAdv Sci Lett2014205984993
   Google Scholar
• GuLOkadaYClintonSKAbsence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient miceMol Cell1998222752819734366
   PubMed Web of Science ®Google Scholar
• MichelsenKSWongMHShahPKLack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein EProc Natl Acad Sci U S A200410129106791068415249654
   PubMed Web of Science ®Google Scholar
• MannAPTanakaTSomasunderamALiuXGorensteinDGFerrariMSite-specific drug delivery: E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrowAdv Mater20112336H284
   Google Scholar
• DeguchiJOAikawaMTungCHInflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivoCirculation20061141556216801460
   PubMed Web of Science ®Google Scholar
• LiCZhangWJFreiBQuercetin inhibits LPS-induced adhesion molecule expression and oxidant production in human aortic endothelial cells by p38-mediated Nrf2 activation and antioxidant enzyme inductionRedox Biol2016910411327454768
   PubMed Web of Science ®Google Scholar
• WuTChenXWangYAortic plaque-targeted andrographolide delivery with oxidation-sensitive micelle effectively treats atherosclerosis via simultaneous ROS capture and anti-inflammationNanomed-Nanotechnol201814722152226
   PubMedGoogle Scholar
• PaolettiRGottoAMJrHajjarDPInflammation in atherosclerosis and implications for therapyCirculation200410923 Suppl 1III-20III-2615198962
   PubMedGoogle Scholar
• ViedtCVogelJAthanasiouTMonocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1Arterioscler Thromb Vasc Biol200222691492012067898
   PubMedGoogle Scholar
• HasanSTZinggJ-MKwanPNobleTSmithDMeydaniMCurcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient miceAtherosclerosis20142321405124401215
   PubMed Web of Science ®Google Scholar
• VallianouNGEvangelopoulosASchizasNKazazisCPotential anticancer properties and mechanisms of action of curcuminAnticancer Res201535264525667441
   PubMed Web of Science ®Google Scholar
• HanssonGKImmune and inflammatory mechanisms in the development of atherosclerosisBr Heart J1993691 SupplS38S418427763
   PubMedGoogle Scholar
• Emini VeseliBPerrottaPde MeyerGRAAnimal models of atherosclerosisEur J Pharmacol201781631328483459
   PubMed Web of Science ®Google Scholar
• GholizadehSVisweswaranGStormGHenninkWEKampsJKokRJE-selectin targeted immunoliposomes for rapamycin delivery to activated endothelial cellsInt J Pharmaceut2017542759770
   Google Scholar
• MaSTianXYZhangYE-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosisSci Rep2016612291026956647
   PubMedGoogle Scholar
• BasnetPHussainHThoISkalko-BasnetNLiposomal delivery system enhances anti-inflammatory properties of curcuminJ Pharm Sci2012101259860921989712
   PubMed Web of Science ®Google Scholar
• MoghimiSMSzebeniJStealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding propertiesProg Lipid Res200342646347814559067
   PubMed Web of Science ®Google Scholar
• LiYChengQJiangQEnhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNAJ Control Release2014176110411424365128
   PubMedGoogle Scholar
• LiYLiuRShiYZhangZZhangXRuiyuanLZwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenonTheranostics20155658359625825598
   PubMed Web of Science ®Google Scholar